{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:23:08Z","timestamp":1791361388627,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672521"],"award-info":[{"award-number":["81672521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974415"],"award-info":[{"award-number":["81974415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372739"],"award-info":[{"award-number":["81372739"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7192021"],"award-info":[{"award-number":["7192021"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,5,28]]},"DOI":"10.1038\/s41388-020-1297-1","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T11:03:07Z","timestamp":1587985387000},"page":"4404-4420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation"],"prefix":"10.1038","volume":"39","author":[{"given":"Yijun","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5921-1297","authenticated-orcid":false,"given":"Junqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4071-4764","authenticated-orcid":false,"given":"Junfang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0022-5347(05)65640-6","volume":"166","author":"AJ Pantuck","year":"2001","unstructured":"Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166:1611\u201323.","journal-title":"J Urol."},{"key":"1297_CR2","doi-asserted-by":"publisher","first-page":"6335S","DOI":"10.1158\/1078-0432.CCR-sup-040026","volume":"10","author":"RC Flanigan","year":"2004","unstructured":"Flanigan RC. Debulking nephrectomy in metastatic renal cancer. Clin Cancer Res. 2004;10:6335S\u201341S.","journal-title":"Clin Cancer Res"},{"key":"1297_CR3","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1200\/JCO.2005.04.8280","volume":"24","author":"SE Eggener","year":"2006","unstructured":"Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol. 2006;24:3101\u20136.","journal-title":"J Clin Oncol"},{"key":"1297_CR4","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1200\/JCO.1993.11.7.1368","volume":"11","author":"LM Minasian","year":"1993","unstructured":"Minasian LM, Motzer RJ, Gluck L, Mazumdar M, Vlamis V, Krown SE. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. J Clin Oncol. 1993;11:1368\u201375.","journal-title":"J Clin Oncol"},{"key":"1297_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4137\/CMO.S4482","volume":"4","author":"J Hadoux","year":"2010","unstructured":"Hadoux J, Vignot S, De La Motte Rouge T. Renal cell carcinoma: focus on safety and efficacy of temsirolimus. Clin Med Insights Oncol. 2010;4:143\u201354.","journal-title":"Clin Med Insights Oncol"},{"key":"1297_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4161\/cbt.19291","volume":"13","author":"H Zhu","year":"2012","unstructured":"Zhu H, Wang Z, Xu Q, Zhang Y, Zhai Y, Bai J, et al. Inhibition of STAT1 sensitizes renal cell carcinoma cells to radiotherapy and chemotherapy. Cancer Biol Ther. 2012;13:401\u20137.","journal-title":"Cancer Biol Ther"},{"key":"1297_CR7","first-page":"117","volume":"78","author":"O Kocher","year":"1998","unstructured":"Kocher O, Comella N, Tognazzi K, Brown LF. Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab Investig. 1998;78:117\u201325.","journal-title":"Lab Investig."},{"key":"1297_CR8","first-page":"6367","volume":"60","author":"MG Ghosh","year":"2000","unstructured":"Ghosh MG, Thompson DA, Weigel RJPDZK1. and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 2000;60:6367\u201375.","journal-title":"Cancer Res."},{"key":"1297_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0002-9440(10)63276-2","volume":"165","author":"J Inoue","year":"2004","unstructured":"Inoue J, Otsuki T, Hirasawa A, Imoto I, Matsuo Y, Shimizu S, et al. Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma. Am J Pathol. 2004;165:71\u201381.","journal-title":"Am J Pathol"},{"key":"1297_CR10","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1038\/onc.2017.199","volume":"36","author":"T Tao","year":"2017","unstructured":"Tao T, Yang X, Zheng J, Feng D, Qin Q, Shi X, et al. PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation. Oncogene. 2017;36:6119\u201331.","journal-title":"Oncogene."},{"key":"1297_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ebiom.2016.12.003","volume":"15","author":"J Zheng","year":"2017","unstructured":"Zheng J, Wang L, Peng Z, Yang Y, Feng D, He J. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma. EBioMedicine. 2017;15:62\u201372.","journal-title":"EBioMedicine."},{"key":"1297_CR12","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1158\/0008-5472.CAN-17-3896","volume":"78","author":"LZ Wen","year":"2018","unstructured":"Wen LZ, Ding K, Wang ZR, Ding CH, Lei SJ, Liu JP, et al. SHP-1 acts as a tumor suppressor in hepatocarcinogenesis and HCC progression. Cancer Res. 2018;78:4680\u201391.","journal-title":"Cancer Res."},{"key":"1297_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.114","volume":"49","author":"CY Liu","year":"2017","unstructured":"Liu CY, Huang TT, Chu PY, Huang CT, Lee CH, Wang WL, et al. The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. Exp Mol Med. 2017;49:e366.","journal-title":"Exp Mol Med"},{"key":"1297_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353\u20138.","journal-title":"Cell."},{"key":"1297_CR15","doi-asserted-by":"publisher","first-page":"13479","DOI":"10.18632\/oncotarget.7266","volume":"7","author":"C Yang","year":"2016","unstructured":"Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D, et al. Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives. Oncotarget. 2016;7:13479\u201390.","journal-title":"Oncotarget."},{"key":"1297_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1158\/0008-5472.CAN-14-2931","volume":"75","author":"H Hirata","year":"2015","unstructured":"Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, et al. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 2015;75:1322\u201331.","journal-title":"Cancer Res."},{"key":"1297_CR17","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1158\/1535-7163.MCT-14-0245","volume":"13","author":"G Yu","year":"2014","unstructured":"Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, et al. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther. 2014;13:3086\u201397.","journal-title":"Mol Cancer Ther"},{"key":"1297_CR18","doi-asserted-by":"publisher","first-page":"38005","DOI":"10.18632\/oncotarget.5357","volume":"6","author":"H Xiao","year":"2015","unstructured":"Xiao H, Tang K, Liu P, Chen K, Hu J, Zeng J, et al. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget. 2015;6:38005\u201315.","journal-title":"Oncotarget."},{"key":"1297_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep13445","volume":"5","author":"T Xia","year":"2015","unstructured":"Xia T, Chen S, Jiang Z, Shao Y, Jiang X, Li P, et al. Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression. Sci Rep. 2015;5:13445.","journal-title":"Sci Rep."},{"key":"1297_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gpb.2016.03.005","volume":"14","author":"F Rashid","year":"2016","unstructured":"Rashid F, Shah A, Shan G. Long Non-coding RNAs in the Cytoplasm. Genomics Proteom Bioinforma. 2016;14:73\u201380.","journal-title":"Genomics Proteom Bioinforma"},{"key":"1297_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00018-017-2591-0","volume":"75","author":"M Olejniczak","year":"2018","unstructured":"Olejniczak M, Kotowska-Zimmer A, Krzyzosiak W. Stress-induced changes in miRNA biogenesis and functioning. Cell Mol Life Sci. 2018;75:177\u201391.","journal-title":"Cell Mol Life Sci"},{"key":"1297_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ygyno.2007.05.009","volume":"106","author":"G Walker","year":"2007","unstructured":"Walker G, MacLeod K, Williams AR, Cameron DA, Smyth JF, Langdon SP. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. Gynecol Oncol. 2007;106:461\u20138.","journal-title":"Gynecol Oncol."},{"key":"1297_CR23","doi-asserted-by":"publisher","first-page":"F973","DOI":"10.1152\/ajprenal.00650.2016","volume":"313","author":"K Prestin","year":"2017","unstructured":"Prestin K, Hussner J, Ferreira C, Seibert I, Breitung V, Zimmermann U, et al. Regulation of PDZ domain-containing 1 (PDZK1) expression by hepatocyte nuclear factor-1alpha (HNF1alpha) in human kidney. Am J Physiol Ren Physiol. 2017;313:F973\u201383.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1297_CR24","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1016\/j.febslet.2008.10.027","volume":"582","author":"K Tachibana","year":"2008","unstructured":"Tachibana K, Anzai N, Ueda C, Katayama T, Yamasaki D, Kirino T, et al. Regulation of the human PDZK1 expression by peroxisome proliferator-activated receptor alpha. FEBS Lett. 2008;582:3884\u20138.","journal-title":"FEBS Lett"},{"key":"1297_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2119\/molmed.2011.00001","volume":"19","author":"H Kim","year":"2013","unstructured":"Kim H, Abd Elmageed ZY, Ju J, Naura AS, Abdel-Mageed AB, Varughese S, et al. PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth. Mol Med. 2013;19:253\u201362.","journal-title":"Mol Med."},{"key":"1297_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0589-7","volume":"13","author":"H Kim","year":"2015","unstructured":"Kim H, Tarhuni A, Abd Elmageed ZY, Boulares AH. Poly(ADP-ribose) polymerase as a novel regulator of 17beta-estradiol-induced cell growth through a control of the estrogen receptor\/IGF-1 receptor\/PDZK1 axis. J Transl Med. 2015;13:233.","journal-title":"J Transl Med"},{"key":"1297_CR27","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99:15524\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR28","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/ijc.24960","volume":"126","author":"I Satzger","year":"2010","unstructured":"Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer. 2010;126:2553\u201362.","journal-title":"Int J Cancer"},{"key":"1297_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/bjc.2012.221","volume":"107","author":"S Miah","year":"2012","unstructured":"Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ, et al. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br J Cancer. 2012;107:123\u20138.","journal-title":"Br J Cancer"},{"key":"1297_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13277-015-4269-2","volume":"37","author":"C Zhao","year":"2016","unstructured":"Zhao C, Wang G, Zhu Y, Li X, Yan F, Zhang C, et al. Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer. Tumour Biol. 2016;37:177\u201383.","journal-title":"Tumour Biol."},{"key":"1297_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1593\/neo.13172","volume":"15","author":"U Weirauch","year":"2013","unstructured":"Weirauch U, Beckmann N, Thomas M, Grunweller A, Huber K, Bracher F, et al. Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma. Neoplasia. 2013;15:783\u201394.","journal-title":"Neoplasia."},{"key":"1297_CR32","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1126\/science.337.6099.1159","volume":"337","author":"E Pennisi","year":"2012","unstructured":"Pennisi E. Genomics. ENCODE project writes eulogy for junk DNA. Science. 2012;337:1159\u201361.","journal-title":"Science."},{"key":"1297_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489:101\u20138.","journal-title":"Nature."},{"key":"1297_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847\u201365.","journal-title":"Nat Rev Drug Discov"},{"key":"1297_CR35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/bib\/bbv061","volume":"17","author":"U Schmitz","year":"2016","unstructured":"Schmitz U, Naderi-Meshkin H, Gupta SK, Wolkenhauer O, Vera J. The RNA world in the 21st century-a systems approach to finding non-coding keys to clinical questions. Brief Bioinform. 2016;17:380\u201392.","journal-title":"Brief Bioinform."},{"key":"1297_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nature09144","volume":"465","author":"L Poliseno","year":"2010","unstructured":"Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465:1033\u20138.","journal-title":"Nature."},{"key":"1297_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cell.2015.02.043","volume":"161","author":"FA Karreth","year":"2015","unstructured":"Karreth FA, Reschke M, Ruocco A, Ng C, Chapuy B, Leopold V, et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell. 2015;161:319\u201332.","journal-title":"Cell."},{"key":"1297_CR38","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.12659\/MSM.893082","volume":"21","author":"Y Chen","year":"2015","unstructured":"Chen Y, Chen J, Liu Y, Li S, Huang P. Plasma miR-15b-5p, miR-338-5p, and miR-764 as biomarkers for Hepatocellular Carcinoma. Med Sci Monit. 2015;21:1864\u201371.","journal-title":"Med Sci Monit"},{"key":"1297_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1586\/14737159.2015.1019477","volume":"15","author":"J Ellinger","year":"2015","unstructured":"Ellinger J, Muller SC, Dietrich D. Epigenetic biomarkers in the blood of patients with urological malignancies. Expert Rev Mol Diagn. 2015;15:505\u201316.","journal-title":"Expert Rev Mol Diagn"},{"key":"1297_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.freeradbiomed.2019.01.030","volume":"134","author":"Y Ma","year":"2019","unstructured":"Ma Y, Qi Y, Wang L, Zheng Z, Zhang Y, Zheng J. SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis. Free Radic Biol Med. 2019;134:458\u201367.","journal-title":"Free Radic Biol Med"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1297-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T19:21:44Z","timestamp":1722799304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-1297-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":40,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,5,28]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-1297-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"1 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}